Estados Unidos · Plataformas y datos · MarketBeat

Takeda Pharmaceutical (NYSE:TAK) Releases Quarterly Earnings Results, Beats Expectations By $0.37 EPS

Publicado por MarketBeat · Estados Unidos hace 2 h

Takeda Pharmaceutical (NYSE:TAK - Get Free Report) posted its earnings results on Thursday. The company reported $0.51 EPS for the quarter, topping analysts' consensus estimates…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Takeda Pharmaceutical (NYSE:TAK) Releases Quarterly Earnings Results, Beats Expectations By $0.37 EPS

También te puede interesar

These 3 Big Risks Could Cause the Next Bear Market. I'm Investing Anyway.

WisdomTree outlines plan to launch 15 to 20 Atlantic House products over 18 to 24 months as Onchain platform expands partnerships

In a wild October for markets, these stocks were the biggest winners and losers

Akari Therapeutics shareholders approve increase in shares for 2023 equity plan

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Cathie Wood's Ark warns of growing threat after Binance hack

Takeda Pharmaceutical (NYSE:TAK) Releases Quarterly Earnings Results, Beats Expectations By $0.37 EPS

Compartir

También te puede interesar

These 3 Big Risks Could Cause the Next Bear Market. I'm Investing Anyway.

WisdomTree outlines plan to launch 15 to 20 Atlantic House products over 18 to 24 months as Onchain platform expands partnerships

In a wild October for markets, these stocks were the biggest winners and losers

Akari Therapeutics shareholders approve increase in shares for 2023 equity plan

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Cathie Wood's Ark warns of growing threat after Binance hack